Clinical Trial Update: A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the safe and effective use of a prefilled safety syringe or auto-injector for subcutaneous self-injection of bimekizumab in a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2023-11-30